MIT’s latest implantable device releasing glucagon automatically when blood sugar drops too low, tested in diabetic mice, ...

MIT 3D prints glucagon-releasing implant for diabetic care. The quarter-sized reservoir sits under the skin and can be ...

Alanine aminotransferase (ALT) levels were greatly reduced with resmetirom and glucagon receptor agonists compared with placebo, with glucagon receptor agonists being linked to the greatest ...

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...

STOCKHOLM — New data on a needle-free nasal delivery system for glucagon for use in severe hypoglycemia presented at the European Association for the Study of Diabetes (EASD) 2015 Meeting here ...